IgE-Mediated Allergen Presentation and Blocking Antibodies: Regulation of T-Cell Activation in Allergy
Authors:
- R.J.J. van NeervenRNR.J.J. van Neerven
- E.F. KnolEKE.F. Knol
- A. EjrnaesAEA. Ejrnaes
- P.A. WürtzenPWP.A. Würtzen
- 1 September 2006
- journal article
- review article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 141 (2) , 119-129
Abstract
It is well established that both the production of IgE by B lymphocytes and the maturation and recruitment of eosinophils in late-phase reactions are dependent on the activation of allergen-specific type-2 T-helper cells. What is less well known is the fact that efficient activation of allergen-specific T cells upon low-dose exposure to allergens is critically dependent on IgE-mediated or -facilitated allergen presentation. In fact, changes in the level of IgE-mediated allergen presentation may account for many of the immunological effects described for specific immunotherapy or anti-IgE treatment. This review aims to summarize the current knowledge, and will discuss the clinical relevance of blocking IgG antibodies induced by specific immunotherapy and anti-IgE monoclonal antibodies that both interfere with IgE-mediated allergen presentation.Keywords
This publication has 98 references indexed in Scilit:
- Inhibition of rBet v 1‐induced basophil histamine release with specific immunotherapy ‐induced serum immunoglobulin G: no evidence that FcγRIIB signalling is importantClinical & Experimental Allergy, 2006
- IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapyEuropean Journal of Immunology, 2003
- The relationship between serum IgE and surface levels of FcϵR on human leukocytes in various diseases: Correlation of expression with FcϵRI on basophils but not on monocytes or eosinophilsJournal of Allergy and Clinical Immunology, 2000
- Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cellsHuman Immunology, 1993
- Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapyJournal of Allergy and Clinical Immunology, 1992
- T cells and eosinophils in the pathogenesis of asthmaImmunology Today, 1992
- A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclassesJournal of Allergy and Clinical Immunology, 1990
- High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergensClinical & Experimental Allergy, 1987
- IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release.Journal of Clinical Investigation, 1976
- Subclass Typing of IgG Antibodies Formed by Grass Pollen-Allergic Patients during ImmunotherapyInternational Archives of Allergy and Immunology, 1976